Physician profile
Arvind Singh Nirula
NPI 1437285095
$19,078.62
in general payments reported to CMS, 2019-2025
44 companies · $2,676 in 2025
The $2,676 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,314 · 2020: $634 · 2021: $2,260 · 2022: $2,736 · 2023: $5,866 · 2024: $2,593 · 2025: $2,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,784 · Travel and Lodging: $2,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,784.48 |
| Travel and Lodging | $2,350.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,146.52 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,421.77 | 2019-2025 | Lifevest |
| Abbott Laboratories | $1,217.28 | 2019-2025 | Cardiomems, Optis, Jot Dx |
| Novartis Pharmaceuticals Corporation | $1,064.45 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $923.17 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $875.59 | 2019-2025 | |
| Inari Medical, INC. | $862.65 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $725.67 | 2021-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Merck Sharp & Dohme LLC | $679.97 | 2021-2025 | Verquvo, Januvia, Capvaxive |
| Abiomed | $572.94 | 2021-2024 | Impella |
| Shockwave Medical, INC | $526.05 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $525.98 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $525.91 | 2019-2024 | |
| Cordis US Corp. | $495.04 | 2025 | Precise Pro Rx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $489.67 | 2019-2025 | Jardiance |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $356.35 | 2020-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $310.36 | 2022-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $287.90 | 2019-2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $285.74 | 2022-2025 | Amvuttra |
| Medtronic Vascular, INC. | $277.72 | 2019-2020 | |
| Cardiva Medical, INC. | $277.43 | 2022-2024 | Savvywire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $270.57 | 2019 | |
| Atricure, INC. | $263.15 | 2023-2025 | Atriclip Laa Exclusion System |
| Medtronic, INC. | $232.08 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $221.27 | 2019-2024 | Watchman Flx, Watchman Access System, Bodyguardian |
| Novo Nordisk INC | $168.96 | 2024-2025 | Wegovy, Ozempic |
| Stryker Corporation | $143.42 | 2025 | Flowtriever |
| Scpharmaceuticals INC. | $112.34 | 2024-2025 | |
| Gilead Sciences, INC. | $111.85 | 2019 | |
| Janssen Scientific Affairs, LLC | $111.06 | 2021 | |
| Amarin Pharma, INC. | $102.34 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $99.97 | 2020-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $70.99 | 2023 | Arcalyst |
| Venclose INC. | $69.90 | 2019 | |
| W. L. Gore & Associates, INC. | $52.77 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.10 | 2025 | |
| Astellas Pharma US INC | $24.44 | 2019 | |
| Altathera Pharmaceuticals LLC | $22.99 | 2025 | Sotalol Hydrochloride |
| Lantheus Medical Imaging, INC. | $22.08 | 2022 | |
| Lundbeck LLC | $19.05 | 2019 | |
| Esperion Therapeutics, INC. | $17.43 | 2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $17.28 | 2023 | Inpefa |
| Ge Healthcare | $14.22 | 2021 | |
| Zoll Respicardia, INC. | $14.20 | 2025 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Nirula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.